Research / Unapproved

Melanotan I: Research Status And Compound Facts

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formula	C78H111N21O19
Molecular weight	1646.8 g/mol
Registered trials	0
PubChem CID	16197727

Regulatory Status

Melanotan I has no approved drug label and is classified as unapproved research material. It is not reviewed by the FDA for safety or effectiveness in humans, and no dosing or clinical use guidance exists in this profile.

What Melanotan I Is

Melanotan I is a synthetic peptide with the molecular formula C78H111N21O19 and a molecular weight of approximately 1,646.8 g/mol (PubChem CID 16197727). Its structure is built from a chain of amino acid residues linked in a defined sequence, consistent with peptides studied for melanocyte-related research pathways. No FDA-approved label, brand name, or mechanism-of-action statement is associated with this compound.

Trial Footprint

Public registries currently list zero registered clinical trials for melanotan I. This means there is no available trial-phase or trial-status information to report at this time.

FAQ

Is melanotan I approved by the FDA?

No. Melanotan I has no FDA-approved label, brand name, or approved indication. It is currently classified as an unapproved research compound.

What is melanotan I chemically?

It is a synthetic peptide with the molecular formula C78H111N21O19 and a molecular weight of about 1,646.8 g/mol. It is catalogued in PubChem under CID 16197727.

Are there clinical trials studying melanotan I?

Public trial registries currently show zero registered studies for melanotan I. As a result, no trial phase, design, or status details are available.

Is there safety or side effect data available for melanotan I?

No adverse event reports or safety datasets are currently available for this compound in this profile. This reflects a lack of reported data rather than a confirmed safety profile.

Why does melanotan I lack an approved label?

Compounds without a completed regulatory review process do not receive an FDA label, indications, or approved brand names. Melanotan I currently falls into this unapproved research category.

This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 16197727 ClinicalTrials.gov registry count

Updated 2026-08-03